Ā | Center 1 n = 20 | Center 2 n = 21 | Center 3 n = 14 | Center 4 n = 7 | Center 5 n = 8 | Center 6 n = 6 | Total n = 76 |
---|---|---|---|---|---|---|---|
Corticoids pulse ā no./total no. (%)+a | 5/20 (25.0) | 9/21 (42.9) | 9/14 (64.3) | 4/5 (80.0) | 6/7 (85.7) | 6/6 (100) | 39/71 (54.9) |
Oral corticoids ā no./total no. (%)a | 15/20 (75.0) | 18/20 (90.0) | 12/14 (85.7) | 3/6 (50.0) | 8/8 (100) | 6/6 (100) | 62/74 (83.8) |
Subconjonctival corticoids ā no./total no. (%)a | 10/19 (52.6) | 5/13 (38.5) | 9/14 (64.3) | 3/3 (100) | 6/7 (85.7) | 6/6 (100) | 39/62 (62.9) |
Intracamerular corticoids ā no./total no. (%)a | 3/19 (15.8) | 5/13 (38.5) | 1/14 (7.1) | 1/3 (33.3) | 1/6 (16.7) | 0/6 (0.0) | 11/61 (18.0) |
Corticoids eyedrops ā no./total no. (%)a | 19/20 (95.0) | 10/10 (100) | 14/14 (100) | 6/6 (100) | 6/6 (100) | 6/6 (100) | 61/62 (98.4) |
Discontinuation of immunosuppressive drugs āno./total no. (%) | 3/20 (15.0) | 0/21 (0.0) | 0/14 (0.0) | 0/7 (0.0) | 2/8 (25.0) | 0/6 (0.0) | 5/76 (6.6) |